Costs and Benefits of Diagnosing Familial Breast Cancer
Based on results from our surveillance program for women at risk for inherited breast cancer, we have calculated cost per year earned. Norwegian National Insurance Service reimbursement fees were used in the calculations. The calculated costs are based on empirical figures for expanding already esta...
Main Authors: | Ketil Heimdal, Lovise Mæhle, Pål Møller |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1999-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/1999/751892 |
Similar Items
-
BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations
by: Åke Borg, et al.
Published: (1999-01-01) -
Use of Cytology to Diagnose Inherited Breast Cancer
by: Pål Møller, et al.
Published: (1999-01-01) -
No Sib Pair Concordance for Breast or Ovarian Cancer in <it>BRCA1 </it>Mutation Carriers
by: Møller Pål, et al.
Published: (2007-06-01) -
Germline PTEN mutations are rare and highly penetrant
by: Rustad Cecilie F, et al.
Published: (2006-12-01) -
Efficacy of Early Diagnosis and Treatment in Women with a Family History of Breast Cancer
by: Pål Møller, et al.
Published: (1999-01-01)